Patrick Heron

Patrick Heron

Director/Miembro de la Junta en ARCUTIS BIOTHERAPEUTICS, INC. .

Fortuna: 2 M $ al 30/06/2026

55 años
Health Technology
Commercial Services
Finance

Perfil

Mr. Patrick J.
Heron
is a Lead Independent Director at MBX Biosciences, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., an Independent Director at Arcutis Biotherapeutics, Inc. and a Managing Partner at Frazier Management LLC.
He is on the Board of Directors at MBX Biosciences, Inc., Mirum Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., Alpha-9 Oncology, Inc., Bluewater Biosciences, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., VentiRx Pharmaceuticals, Inc., Zavante Therapeutics, Inc. and Calibrium LLC.
Mr. Heron was previously employed as an Independent Director by HilleVax, Inc., an Independent Non-Executive Director by Passage Bio, Inc., a Chairman by Scout Bio, Inc., an Independent Director by Vaxcyte, Inc., an Independent Director by Iterum Therapeutics Plc, an Independent Director by Tobira Therapeutics, Inc., an Independent Director by Imago BioSciences, Inc., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by Collegium Pharmaceutical, Inc., an Independent Director by Tobira Therapeutics, Inc. /Old/, an Engagement Manager by McKinsey & Co., Inc., a Principal by Cetus Corp., a Chairman by Kalidex Pharmaceuticals, Inc., and a Principal by The General Hospital Corp.
He also served on the board at SanReno Therapeutics, Silvergate Pharmaceuticals, Inc., Calixa Therapeutics, Inc., Marcadia Biotech, Inc., Cerexa, Inc., Trubion Pharmaceuticals, Inc., MedPointe, Inc., QuatRx Pharmaceuticals Co., Amunix, Inc., ARMO Biosciences, Inc., Avera Pharmaceuticals, Inc., Chimerix, Inc., Ignyta, Inc., Informed Medical Communications, Inc., Moximed, Inc., Panomics LLC, PreCision Dermatology, Inc. and Recida Therapeutics, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Harvard Business School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
05/06/2026 32.213 ( 0,03 % ) 844 625 $ 30/06/2026
15/06/2026 5.703 ( 0,01 % ) 667 650 $ 30/06/2026
0,03 %
31/01/2025 9.110 ( 0,03 % ) 614 925 $ 30/06/2026
0,02 %
01/11/2025 14.937 ( 0,02 % ) 162 066 $ 30/06/2026
04/06/2026 0 ( -.--% ) - $ 30/06/2026

Cargos activos de Patrick Heron

EmpresasCargoInicio
ARCUTIS BIOTHERAPEUTICS, INC. Director/Miembro de la Junta -
MIRUM PHARMACEUTICALS, INC. Director/Miembro de la Junta 07/11/2018
MBX BIOSCIENCES, INC. Director/Miembro de la Junta 01/07/2020
Inversor de Capital Privado 01/08/1999
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -

Antiguos cargos conocidos de Patrick Heron.

EmpresasCargoFin
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Patrick Heron.

Formación de Patrick Heron.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

75

Relaciones de 1er grado

45

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas45

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services